Jürgen Engel
Nessuna posizione attualmente
Profilo
Dr. Jürgen Engel is President & Chief Executive Officer at AEterna Zentaris, Inc. He is on the Board of Directors at Isotechnika Pharma, Inc.
Dr. Engel was previously employed as Chief Executive Officer by Zentaris GmbH.
He received his undergraduate degree from the University of Regensburg and a doctorate degree from the Technical University of Braunschweig.
Precedenti posizioni note di Jürgen Engel
| Società | Posizione | Fine |
|---|---|---|
| AETERNA ZENTARIS INC. | Presidente | 15/04/2013 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direttore/Membro del Consiglio | 18/02/2011 |
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Amministratore Delegato | - |
| Zentaris GmbH | Presidente | - |
Formazione di Jürgen Engel
| University of Regensburg | Undergraduate Degree |
| Technische Universität Braunschweig | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Zentaris GmbH | |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Jürgen Engel
